DIGILUNG takes a new step in Personalised medicine to address the global challenge of COPD. DIGILUNG taps into the sourcing of technological capabilities from advanced, less advanced and transition regions to scaleup 3 key industrial pilots (through TRL7-8 up to market uptake) and develop an integrated solution for their sustainable integration over time. DIGILUNG will scale up 3 AI-based innovations from 3 business-driven pilots, and further their deployment by building a holistic solution that will link them to each other. DIGILUNG will generate a wide range of spill-over effects: productivity gains, reduce cost of COPD, and generate new data & tech
|Effective start/end date||1/09/23 → 31/08/26|
- Personalised medicine
- digital health
- chronic disease
Flemish discipline codes
- Other health sciences not elsewhere classified
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.